lilly self pay tirzepatide Eli has launched new self-pay options for tirzepatide, introducing 7.5 mg and 10 mg single-dose vials for $499 through the Zepbound Journey Program. This initiative, available exclusively via LillyDirect Eli Lilly, Maker of Mounjaro

Rnn PF, Andersen GS, Lauritzen T, Christensen DL, Aadahl M, Carstensen B, et al

After 36 weeks of tirzepatide-induced weight loss (mean 20.9%), participants randomized to placebo regained a mean of 14.8% of body weight over 52 weeks

LifeScan Utilization Management and Formulary Deletion Product Removal & UM Changes : Due to LifeScans Chapter 11 bankruptcy, OneTouch diabetic test strips and meters will be removed from Highmarks Commercial and Exchange formularies starting September 15, 2025

2018;20(Suppl 1):2233

Your clinician should tailor this to your situation and, importantly, to the underlying cause of deficiency (dietary vs non-dietary)